Natural Killer Cell Tolerance in Mice with Mosaic Expression  of Major Histocompatibility Complex Class I Transgene by Johansson, Maria H. et al.
Natural Killer Cell Tolerance in Mice with Mosaic Expression 
of Major Histocompatibility  Complex Class I Transgene 
By Maria H.Johansson,* Charles Bieberich,¢ Gilbert Jayfi Klas K~irre,* 
and Petter H6glund* 
From the *Microbiology and Tumor Biology Center, Karolinska Institute, S-171 77 Stockholm, 
Sweden; and the *Department of Virology,  Jerome H. Holland Laboratory, Rockville, Maryland 28255 
Summary 
We  have  studied  natural  killer  (NK)  cell tolerance in  a  major histocompatibility complex 
(MHC) class I transgenic line, DL6, in which the transgene product was expressed on only a 
fraction of blood cells.  In contrast with transgenic mice expressing the same transgene in all 
cells, NK cells from mosaic mice failed to reject transgene-negative bone marrow or lymphoma 
grafts. However, they retained the capability to reject cells with a total missing-selfphenotype, 
i.e., cells lacking also wild-type MHC class I molecules. Tolerance against  transgene-negative 
cells was demonstrated also in vitro, and could be broken if transgene-positive spleen cells of 
mosaic mice were separated from negative cells before, or after 4 d of culture in interleukin-2. 
The results  provide support for selective NK cell tolerance to one particular missing-selfphe- 
notype but not to another. We suggest that this tolerance is determined by NK cell interactions 
with multiple cells in the environment, and that it is dominantly controlled by the presence of 
cells lacking a specific MHC class I ligand. Furthermore, the tolerant NK cells could be reacti- 
vated in vitro, which suggests  that the tolerance occurs without deletion of the potentially au- 
toreactive NK cell subset(s),  and that it may be dependent upon the continuous presence of 
tolerizing cells. 
N 
K  cells kill tumor cells and virus-infected cells (1-3), 
regulate hematopoiesis (4),  and mediate rejection of 
MHC mismatched hematopoietic grafts (5, 6). The molec- 
ular interactions that take place during NK cell recognition 
are incompletely understood, but one important factor for 
NK cell sensitivity is the MHC class I expression of the tar- 
get.  In contrast with T  cells,  which require MHC  class I 
expression by target cells to initiate lysis, NK cells preferen- 
tiaUy  kill  cells  lacking  MHC  class  I  expression  (7-13). 
However, NK cell recognition does not depend on com- 
plete MHC class I deficiency on the graft. Failure of a tar- 
get cell to express one specific MHC  class I allele may be 
suflqcient  to  trigger NK  cells.  This  mechanism  was  sug- 
gested as one explanation of hybrid resistance, a phenome- 
non in which NK cells  of F1  hybrid mice reject parental 
hematopoietic grafts  (reviewed in reference 6).  According 
to the missing-self hypothesis, parental cells would be re- 
jected by  F1  hybrid  mice  because  they  fail  to  express  a 
complete set of host MHC  class I  alleles  (7,  9).  Evidence 
for this hypothesis has been obtained in experiments with 
MHC  class I  transgenic mice. Introduction of a D a trans- 
gene in C57BL/6  (t36) mice conveyed NK cell-mediated 
rejection of nontransgenic, but otherwise syngeneic, grafts 
(14,  15). Transfection of the D s gene to the sensitive target 
led  to  escape  from  rejection,  suggesting  that  killing  was 
triggered by missing self (16-18). 
The results  described above suggest  that  the  ability  to 
recognize cells lacking one or several specific MHC class I 
alleles may represent a general strategy in NK cell function. 
The identification of MHC  class I-specific inhibitory re- 
ceptors on NK  cells,  such  as  the  members  of the  Ly-49 
family in the mouse (19-21) and the p58/p70 molecules in 
human  (22-24) have recently given molecular support for 
this concept. When NK cells carrying these receptors meet 
target cells expressing the correct MHC class I ligands,  lysis 
is inhibited (19, 21, 25, 26). Furthermore, host MHC class 
I  alleles  also  influence the  expression and function of the 
inhibitory receptors (27-30).  These results emphasize the 
pivotal role of host MHC class I molecules in the develop- 
ment of NK cell specificity, and raise  questions as to how 
MHC class I molecules educate NK cells and how self-tol- 
erance is secured. 
In contrast with T  and B cells, little is known regarding 
the mechanisms  that induce NK cell tolerance and about 
the properties of the tolerant NK cells. Attempts to induce 
tolerance in F 1 mice by inoculating parental cells have been 
made (31-36), but the interpretations of such experiments 
have been difficult. First,  the recipients were mostly adult 
mice containing mature NK cells, which may not be ideal 
for the  study of how tolerance would develop normally. 
Second, the  inoculated parental  cells  were in many cases 
mature immunocompetent cells, which makes it difficult to 
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and  nonspecific effects of graft versus host disease.  Third, 
there have been no studies of  NK cell tolerance to cells lacking 
specific self-MHC class I alleles. 
In the present report, we have studied the development 
of the NK cell repertoire and NK cell tolerance to self  in an 
MHC  class I  transgenic mouse  (DL6)  in which  the trans- 
gene Dd/L  d (otl/cx2 domains of D a coupled to the or3  do- 
main,  transmembrane  and  intracellular domains  of L a)  is 
spontaneously expressed in only a fraction (10-80%)  of the 
hematopoietic  cells.  This  model  has  allowed  us  to  ask  a 
number  of questions  about  the  role  of host MHC  class I 
molecules in NK cell development. (a) Are the MHC  class 
I molecules expressed by the NK cells themselves sufficient 
to determine their specificity, or are interactions with other 
cells necessary?  (b)  If interactions with  other cells are im- 
portant, would the presence of cells selectively deficient in 
a  particular MHC  class I  hgand dominantly control toler- 
ance  to  these  cells?  Alternatively, would  the  interaction 
with cells expressing a particular ligand be sufficient to in- 
struct NK cells to kill cells lacking this ligand? (c)  Is toler- 
ance to  different missing-self phenotypes controlled selec- 
tively and  independently?  (d)  Are potentially autoreactive 
NK cells deleted in a selection process or can they persist as 
anergized or specifically tolerized cells? (e) In the latter case, 
is the specificity of an NK cell a permanent property or can 
it be altered? 
Materials and Methods 
Mice and Cell Lines.  Mice were kept and bred at the Micro- 
biology and Tumor Biology Center (MTC; Karolinska Institute, 
Stockholm, Sweden).  The  transgenic DL6  mice were made by 
microinjecting an MHC class I gene construct (pG24) containing 
the ed/a2 domains from D d and the c~3 plus the intracellular do- 
mains from L  d (37) into CD1  ×  B6 embryos. The founder mice 
were  screened for presence  of the  transgene by Southern  blot 
analysis and the DL6 founder was selected for subsequent back- 
crossing to B6.  DL1  mice were made using the same gene con- 
struct microinjected into embryos derived from inbred B6 mice. 
These founder mice were screened by immunofluorescence anal- 
ysis  of peripheral blood lymphocytes, using antibodies directed 
against the transgene product. The DL1 transgenic hne has previ- 
ously been described as T62UL (17). The generation ofD  a trans- 
genic D8 mice (38)  as well as ~2-microglobulin (132m)-deficient 
mice  (39)  has  been  described  earher.  Nontransgenic  B6  mice 
were used as controls and were purchased from B&K Universal 
AB  (S011entuna,  Sweden)  or from  Bomholtg~rd Breeding and 
Research Centre (R.y, Denmark): The cell line RMA is a subline 
of RBL-5, which is a Rancher virus-induced T cell lymphoma of 
B6 origin. RMA-S is a TAP-2-deficient variant of KMA. 
Antibodies and Reagents.  The following mAbs were purchased 
from Pharmingen (San Diego, CA): 3-25.4 (anti-od/(x2 domains 
of Dd;  FITC conjugated), PK136  (anti-NKl.1; PE  conjugated), 
500A2 (anti-CD3; PE conjugated),  R3-6B2  (anti-CD45R [B220]; 
PE conjugated), A1 (anti-Ly-49A; biotinyhted), and SW5E6 [anti- 
Ly-49C and Ly-49I]; PE conjugated). The hybridomas 34-4-21S 
(anti-(xl/o~2 domains  of Dd), YTS  169  (anti-CD8),  YTS  156 
(anti-CD8), and M5/114.15.2  (anti-I-A  TM and I-E  d,k) was  ob- 
tained  from  American  Type  Culture  Collection  (R.ockville, 
MD).  YT3.1.2  and YTS  191  (anti-CD4) were from European 
Collection of  Animal Cell Cultures (Porton Down, UK). 1D9 (anti- 
I-A) supematant was a gift from Dr,  C. Watts via B.  Chambers 
(Karolinska  Institute,  Stockholm,  Sweden).  Streptavidin-Red670 
conjugate  was  purchased  from  Life  Technologies  AB  (T~iby, 
Sweden). 
Preparation of Cells and FACS  ~ Analysis.  Cells  from  periph- 
eral blood or spleen were pelleted, resuspended in water for 20 s 
to lyse the erythrocytes and subsequently washed in PBS contain- 
ing 1% FCS. IL-2-activated spleen cells were washed once and 
resuspended in PBS with 1% FCS. The cells were then incubated 
with labeled mAb for 30  rain  on  ice,  washed,  resuspended in 
PBS, and analyzed on a FACScan  ® (Becton Dickinson, Mountain 
View, CA). To analyze mice for presence of the IY/L  d transgene, 
peripheral blood cells  (106) were stained with FITC-conjugated 
antibody against the cd/ot2 domains of D a (3-25.4). Cells other 
than lymphocytes were gated out and 5,000 cells were analyzed. 
Double staining of cells from spleen was used to analyze for trans- 
gene  expression in  different cell types.  Spleen cells were  incu- 
bated with PE-conjugated mAbs directed against markers for B, 
T, or NK cells together with FITC-conjugated antibody against 
the cxl/ot2 domains ofD  d. The gate was set to exclude other cells 
than lymphocytes and compensation was  set to  correct for the 
registration of FITC flourescence on  the PE  detector and vice 
versa. 
To analyze for expression of NK cell receptors, NK cells were 
enriched from mouse splenocytes  as follows:  erythrocyte-depleted 
splenocytes were resuspended in RPMI 5+  (R.PMI medium sup- 
plemented  with  10%  FCS,  100  U/ml  penicillin,  100  p,g/ml 
streptomycin, nonessential amino acids,  1 mM sodium pyruvate, 
and  50  p,M 2-ME)  and loaded onto  nylon wool  (Polyscience, 
Eppelheim,  Germany)  columns  that  had  been  preincubated at 
37°C for 1 h. The columns were incubated at 37°C with 5% CO2 
for  1 h,  after which nonadherent cells were eluted with RPMI 
5+. The eluted cells were depleted of cells expressing MHC class 
II,  CD4,  and  CD8  by incubating  107  cells with  mAbs against 
MHC class II, CD4, and CD8 for 30 min on ice followed by in- 
cubation with rabbit complement for 1 h at 37°C. The cells were 
washed three times and were then in a first step incubated with 
biotinylated antibody against Ly-49A, washed,  and incubated with 
FITC-conjugated antibody against the otl/ot2 domains of D a to- 
gether with PE-conjugated antibody against Ly-49C/I and Strepta- 
vidin-Red670. A gate was set to exclude cells other than lympho- 
cytes. This gate was combined with gates for D O  ed/ot2-negative or 
D d otl/ot2-positive cells for analysis of Ly-49 expression. Staining 
for D a cd/ot2 and NKI.1  in combination with Ly-49A or Ly- 
49C/I in the same experiment was included to determine the ex- 
pression of NKl.1 in relation to Ly-49A or Ly-49C/I. 
Tumor Growth Experiments.  103  or  104  tumor cells (kept as 
ascites line in the peritoneal cavity of syngeneic mice) were inoc- 
ulated subcutaneously into the right flank of age-matched DL6, 
DLt, B6, and D8 mice. The growth of the sohd tumors was fol- 
lowed by  weekly palpations.  To  deplete  NK  cells  in  control 
mice, 0.2 ml ofanti-NKl.1 mAb (ascites preparation) was inocu- 
lated intraperitoneally  2 d before inoculation of tumor cells as de- 
scribed (40). 
Bone Marrow Transplantation Experiments.  Bone  marrow cells 
(BMC) 1 were  obtained from donor mice by crushing the tibia 
and femur in PBS using mortar and pestle. The cells were washed 
1Abbreviations used in this paper: BMC, bone marrow cells;  MPC, magnetic 
particle concentrator. 
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ulated intravenously in the tail vein of irradiated (800 rads) recip- 
ient mice. Control mice were given 0.2 ml anti-NKl.1 mAb (as- 
cites preparation) intraperitoneally 2 d before to deplete NK cells. 
After 5 d, 0.5 p~Ci 5-[12sI]-iodo-2'-deoxyuridine ([1251]dUrd) was 
inoculated intraperitoneally. To inhibit endogenous thymidylate 
synthetase,  5-fluoro-2'-deoxyuridine (FdUrd;  25  ~g  in 0.1  ml 
RPMI) was inoculated intraperitoneally 1 h  before. The follow- 
ing day the mice were killed and incorporated radioactivity in the 
spleens was  measured in a  ~/-counter. Transplantation to  either 
syngeneic hosts or NK cell-depleted hosts were included in each 
experiment to test for the ability of the BMC to engraft after in- 
oculation. In all experiments, groups recieving no BMC were in- 
cluded as irradiation controls. 
Cell Separation Using Immunomagnetic Beads.  Rat  anti-mouse 
IgM-conjugated immunomagnetic beads,  M-450  (Dynal, Oslo, 
Norway) were preincubated with IgM antibody against D d cd/o~2 
(34-4-21S)  at  4°C for 30  rain.  1.5  ~g antibody/mg beads was 
used. Erythrocyte-depleted splenocytes, or day 4  IL-2-activated 
NK cells, were incubated with the precoated beads for 30 min at 
4°C. Cells bound to the beads were then collected with a mag- 
netic  particle  concentrator  (MPC;  Dynal,  Oslo,  Norway),  and 
washed  4-5  times.  Unbound cells were  once  again put  in the 
MPC to remove remaining bead-bound cells from the superna- 
tant. All incubations and washes were  made in PBS  containing 
0.1% BSA. After separation, Da/La-positive  and Dd/Ld-negative 
cells were  cultured separately in rlL-2 and used as NK effector 
cells after 4 d (or 1 d in the case of the day 4 IL-2-activated cells). 
In the Da/Ld-positive culture the beads were present during IL-2 
activation. They were  removed using the MPC before the NK 
cells were used as effector cells and in FACS  ® analysis. As a con- 
trol,  DL1  cells  were  incubated with precoated  beads,  collected 
with the MPC,  and cultured in presence of the beads.  This did 
not affect the ability to lyse target cells (data not shown). 
Generation of IL-2-activated  NK Cells and  Concanavalin A-acti- 
vated Lymphoblasts.  Effector  cells were  generated  as  described 
(17,  41).  In brief, spleen cells were cultured at 37°C in complete 
medium (oL-MEM containg 10% FCS,  100 U/mi penicillin, 100 
p~g/ml streptomycin, 10 mM Hepes buffer, and 2  ×  10 -5 M 2-ME) 
in the presence of 1,000 U/ml of rlL-2 and in a  10% CO  2, 90% 
air mixture. After 4 d both adherent and nonadherent cells were 
removed and used as effector  cells. The starting material in this study 
was either (a) erythrocyte-depleted spleen cells, or (b) fleshly sepa- 
rated bead-bound (Dd/Ld-positive) or unbound (Da/La-negative) 
spleen cells. To generate lymphoblasts, erythrocyte-depleted spleen 
cells  were  cultured for 48  h  in complete medium supplemented 
with 3 p~g/ml Con A  (Sigma, St. Louis, MO). Before use as target 
cells in a standard SlCr-release assay, dead cells were removed by cen- 
trifugation with Lymphoprep (Nycomed, Oslo, Norway). 
Cytotoxicity Assay.  The  assay  was  performed  in  complete 
medium. Effector cells were used at effector to target ratios from 
100:1 to 3.7:1, and 5  ×  103 target cells (labeled with 5tCr) were 
plated per well. Each E/T ratio was assayed  in triplicate. The as- 
say was incubated in 37°C and after 4 h 70 ILl ofsupernatant was 
harvested and the radioactivity of each sample was determined by 
counting in a ",/-counter. Percent specific lysis was calculated as 
follows: percent  specific lysis  =  ([cpm  experimental release  - 
cpm spontaneous release]/[cpm maximum release -  cpm sponta- 
neous release])  ×  100.  The  spontaneous release  represents  the 
51Cr release from target cells incubated in the absence of effector 
cells,  experimental release represents the release from target cells 
incubated with effector cells and maximum release represents the 
SlCr content ofresuspended target cells. 
Results 
Expression and Inheritance of the Dd/L a Transgene.  The 
Da/L  a transgene is an exon-shuffled gene containing exons 
1-3 from D a coupled to exons 4-8 from L a (37).  The chi- 
meric protein is thus composed  of the cd/ct2  domains of 
D d hnked to  the  oL3, transmembrane and intracellular do- 
mains  of L a.  Because  the  construct  contains  an  endoge- 
neous MHC  class I promoter, expression in all cells was ex- 
pected in transgenic mice  (38).  However,  flow cytometry 
analysis  of peripheral  blood  lymphocytes,  using a  FITC- 
conjugated antibody directed against the otl/ct2 domains of 
D d,  showed  variations in  staining patterns  between  mice 
originating from different founders (Fig. 1). Two transgenic 
mouse lines  (DL1  and DL6)  were  used  in  this  study.  DL1 
mice behaved as expected; mice from backcrosses ofhemi- 
zygous DL1  mice to B6 had either only Dd/Ld-negative or 
Dd/Ld-positive  lymphocytes  (Fig.  1,  E-F).  In  contrast, 
when mice from the DL6 founder backcrossed to B6 were 
analyzed, some of the offspring gave rise to histograms with 
only  one  negative  peak  (negative  phenotype;  Fig.  1  A), 
whereas  other mice showed  two  populations, one Da/L a- 
negative  and  one  Da/Ld-positive  (mosaic phenotype;  Fig. 
1, B-D). Further analysis of the DL6 line suggested that the 
transgene was inherited in a Mendehan fashion, segregating 
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Figure  1.  FACS  ® analysis of peripheral blood cells of progeny from 
hemizygous DL6 mice backcrossed to B6. Cells were stained with FITC- 
conjugated antibody directed against the ctl/cc2 domains of D a and ana- 
lyzed on a FACScan  ®. The histograms show analyses of cells from one 
transgene-negative and three transgene-positive DL6 mice (A-D), as well 
as from one transgene-negative and one transgene-positive DL1 mouse (E 
and F). 
355  Johansson et al. Table  1.  Inheritance  of the Dd/L  d Transgene in DL6 Mice 
Backcrossed to B6* 
Parents 
Backcross  Male  Female 
Transgene-positive 
pups/total number of pups 
(percentage of total) 
4  DL6 +/--  B6  55/109 (50) 
5  DL6 +/-  B6  51/110 (46) 
5  B6  DL6 +/-  38/77 (49) 
*  Presence of the transgene in offspring from the backcrosses was de- 
tected by FACS  ® analysis of peripheral blood leucocytes stained with 
the 3-25.4 antibody (anti-D a otlAx2). 
as a single autosomal dominant gene with the negative phe- 
notype representing  transgene-negative  mice and the  mo- 
saic  phenotype  representing  transgene-positive  mice.  In  a 
backcross analysis, 55 of 109 mice (50%) were phenotyped 
as mosaic (29 males and 26 females) and 54 as negative (29 
males and 25 females) (Table  1), and when presence of the 
transgene  was assessed by Southem  blot analysis on a bru- 
ited  number  of mice,  all mice  of the  negative  phenotype 
typed as negative  at the  gene level, whereas  all mice with 
the  mosaic phenotype  typed as positive  (data not  shown). 
Mice of negative phenotype will be termed transgene-neg- 
ative and the mice of mosaic phenotype transgene-positive 
with respect to genotype. The cells from transgene-positive 
mice will be denoted  Da/L  d positive and Da/L  a negative. 
The  transgene  was expressed similarly in  male and  female 
mice, excluding X  chromosome inactivation as an explana- 
tion  for the  mosaicism.  The  transmission  and  the  expres- 
sion  pattern  in  the  offspring  were  also  independent  of 
whether the transgene was inherited  from the father or the 
mother  (46%  vs.  49%  of offspring positive),  which  made 
conventional  parental  imprinting  an  unlikely  explanation 
(Table 1). 
Although  the percentage  of Da/La-positive  cells  appeared 
constant in individual mice, it showed a wide variation be- 
tween  different  DL6  mice,  ranging from  10  to  80%  (Fig. 
1). This suggested that the  expression pattern in peripheral 
blood  was  not  a  result  of cell  type-specific  expression. 
Two-color immunofluorescence  analysis, in which spleno- 
cytes  from  DL6  mice  were  stained  for  expression  of the 
transgene  product  and  for markers  of B,  T,  or  NK  cells, 
showed that each of these cell populations were composed 
of Dd/Ld-positive as well as Da/La-negative cells (Fig. 2). In 
five individually  analyzed  mice,  the  percentage  of Da/L a- 
positive T  and B  cells closely resembled the percentage  of 
positive cells in whole spleen. The distribution  of NK cells 
was shghfly shifted  towards  Da/Ld-positive  cells compared 
with the total spleen cell distribution,  but the total number 
of NKl.l-positive  cells  was  not  different  between  DL6, 
DLI,  and B6 mice  (data  not  shown).  The mosaic  expres- 
sion  pattern  was  also  seen  in  fibroblasts  that  had  been 
treated with  IFN-~/to  induce  expression  of MHC  class  I, 
which indicated that the expression pattern of the transgene 
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Figure  2.  Two-color immunofluorescence analysis of transgene ex- 
pression in different spleen cell populations. Spleen cells from B6, DL6 
(48% positive cells in peripheral blood)  and DL1  mice were  double- 
stained using a mAb specific for D  a otl/ot2 in combination with mAbs 
specific for T cells (CD3), NK cells (NKI.1), and B cells (B220) and ana- 
lyzed on a FACScan  ®. 
can  not  be  overruled  by induction  with  IFN-y  (data  not 
shown). This also indicated that the regulation of transgene 
expression is cell lineage independent,  suggesting that it is 
determined early in embryonic development. 
NK Cells in DL6 Mice Are Tolerant to Da-negative  as well as 
Dd-positive Grafts.  To test the ability of NK cells  in Da/L  d- 
transgenic mice to reject H-2b-positive but Da/La-negative 
lymphoma cells, RMA  tumor cells (of B6 origin)  were in- 
oculated subcutaneously into DL6, DL1, B6,  and D8 mice 
(Table 2).  In contrast with D8  and DL1  mice, which both 
resisted  the  tumor,  mosaic  DL6  mice  all  developed  large 
tumors  within  2  wk  after  inoculation.  This  was  also  the 
case with anti-NKl.l-treated  DL1  and D8  mice and with 
nontransgenic  B6 mice.  The failure of DL6 mice to reject 
RMA  tumor cells was not related to the number of Dd/L  d- 
positive cells in the mosaic mice; animals with 80% positive 
cells were as susceptible to tumor growth as those with 18% 
positive  cells  (included  in  Table  2).  This  finding  argues 
against  the  possibility  that  the  mosaic  mice  have  too  few 
Dd/Ld-positive  NK  cells  to  eliminate  transgene-negative 
cells. The fact that the mice failed to reject even a low dose 
of tumor cells also speaks against this alternative  (Table 2). 
Mosaic DL6 mice were also unable to reject bone marrow 
grafts of the H-2  b haplotype (Fig. 3 A), and IL-2-activated 
NK cells from DL6 mice failed to kill B6-derived lympho- 
blasts in vitro (Fig. 4). In contrast, NK cells from DL1 mice 
rejected  H-2  b bone  marrow grafts in vivo (see Fig.  3)  and 
killed B6-derived lymphoblasts in vitro (Fig. 4). Thus, they 
356  NK Cell Tolerance in Mosaic MHC Class I Transgenic Mice Table 2.  Growth of RMA  and RMA-S Lymphoma  Cells in B6, D8, DL1, and DL6 Mice* 
Recipient Mice 
H-2 Haplotype  Tumor Takes 
K, D  Transgene  Transgene expression  tLMA 
c~ 1/c~2/ot3  103  104 
RMA-S 
10 4 
B6  b, b  -  -  11/12  47/47 
B6, anti-NKl.1  b, b  .... 
DL6  b, b  Dd/Dd/L a  Mosaic  5/6  24/24 
DL6, anti-NKl.1  b, b  Dd/Dd/L d  Mosaic  -  - 
DL1  b, b  Da/Dd/L d  All cells  -  0/10 
DL1, anti-NKl.1  b, b  Dd/Dd/L d  All cells  -  6/6 
D8  b, b  Dd/Dd/D a  All cells  1/8  2/23 
D8, anti-NKl.1  b, b  Da/Dd/D a  All cells  -  6/6 
0/13 
6/6 
0/12 
6/6 
"103 or 104 (RMA) or 104 (RMA-S) tumor cells were inoculated subcutaneously  in normal or in NK cell-depleted mice (anti-NKl.1) and growth of 
the solid tumors was followed by weekly palpations.  The ratio indicates number of mice with tumors over the total number of inoculated. Dashes in- 
dicate  not applicable  (with regard to H-2 haplotype)  or not done (with regard to tumor takes). Summary from 1-4 separate experiments depending 
on tumor host combination. 
behaved  as  transgenic  mice  expressing  a  normal  D d trans- 
gene (15,  17). 
It may be  argued  that  Da/La-positive  NK  cells  are  not 
tolerant but in fact continuously react against Da/Ld-nega- 
five cells in the  mosaic  mice.  The latter would  act as cold 
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Donor/Recipient  Combination 
Figure 3.  Bone marrow growth in B6, DL6 and DL1 mice. 106 bone 
marrow cells from B6 and D8 donors  (A) or ~2  m-/- (-/-)  donors  (B) 
were gra&ed by intravenous inoculation  to irradiated (800 rads) recipients. 
On day 5, 25 I~g of 5-fluoro-2'-deoxyuridine was inoculated  intraperito- 
neaUy followed by  another  intraperitoneal  inoculation  of 0.5  I~Ci of 
5-[12sI]iodo-2'-deoxyuridine  (12SIdUrd) 1 h later. The following day the 
mice were killed and incorporated  radioactivity in the spleens was mea- 
sured in a ~/-counter. Geometric means and SD were calculated from two 
pooled experiments  in all donor/recipient combinations  except for B6/ 
B6 and B6/DL6 where three experiments  were pooled, and B6/DLI*, 
-/-/B6* and -/-/DL6* where data was from one experiment.  No ex- 
periment contained  less than five mice per donor/recipient combination. 
Asterisks indicate  recipient mice pretreated  with anti-NKl.1  antibody. 
Minus signs indicate no bone marrow inoculated. 
target competitors and prevent recognition of Dd/Ld-nega - 
tive grafts or target cells. However, the DL6 mice appear to 
be healthy and breed normally,  and we have not observed 
any signs of wasting disease in these mice. Furthermore,  the 
relative amount  of transgene-positive  cells versus  negative 
cells did not change significantly with time, arguing against 
continuous destruction oftransgene-negative cells (data not 
shown). 
Normal B6 mice have been shown to reject Dd-positive 
bone  marrow  cells from D8  mice  (15,  42).  This  rejection 
has been suggested to reflect positive recognition of foreign 
MHC  class  I  molecules by  NK  cells.  It was  interesting  to 
note that, in contrast with B6 mice, D8-derived bone mar- 
row cells were not rejected in DL6 mice (see Fig. 3 A). IL-2- 
activated NK  cells from DL6 mice were also unable to kill 
Dd/Ld-positive  lymphoblasts  in  vitro  (Fig.  4).  However, 
the  latter  finding was  not  surprising  because  previous  ex- 
periments  have shown that  the rejection of D8 bone  mar- 
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Figure 4.  In vitro cytotoxicity of IL-2-activated NK cells. IL-2~acti- 
vated NK cells from B6 (circles), DL1  (diamonds), and DL6 (squares) mice 
were tested  in a  chromium release assay using  lymphoblasts  from B6, 
DL1, and J32m  -/- mice as target cells. Target cells are indicated in the up- 
per right comer of each graph. The figure shows one experiment out of 
three with similar results. 
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[32m-deficient  lymphoblasts  in  vitro  with  a  similar  effi- 
ciency as NK cells from DL1  and B6 mice (Fig. 4).  These 
results showed that the tolerance in DL6 mice was neither 
due to a general deficiency in killing potential nor to a gen- 
erally abrogated capacity to distinguish between MHC class 
B6  I-negative  and  positive  cells.  The  results  rather  suggested 
that  the  tolerance  was  specific  for  cells  of the  tolerizing 
phenotype. 
Tolerance Against  Da/La-negative Cells in  DL6 Mice Can 
Neither Be Explained by Complete Deletion of the Ly-49A Sin- 
gle-positive cells, Nor by  Coexpression of Ly-49C on All Ly- 
49A-positive NK Cells.  It has been shown that the killing 
of H-2b-positive but Da-negative  cells by D8 NK cells in 
vitro is mediated by the Ly-49A  + subset  (29).  One way to 
abrogate  this  reactivity  would  be  to  ensure  that  the  Ly- 
49A  + NK cells coexpressed an additional receptor mediat- 
ing inhibition by interaction with H-2  b ligands on the tar- 
get cell.  Ly-49C has been suggested to mediate  inhibition 
of lysis  of Kb-expressing target cells  (26).  If such a mecha- 
nism for tolerance was operating in the DL6 mice, all, or at 
least  an increased number of, Ly-49A  +  cells  would coex- 
DL6  press Ly-49C. To test this hypothesis, we performed FACS  ® 
analysis of NK cells  purified from fresh mouse splenocytes. 
The  cells,  in  general  consisting  of 60-90%  NKI.1 +  cells, 
were  triple-stained  for  Ly-49A,  Ly-49C,  and  D a.  These 
experiments  showed  a  similar  proportion  of  Ly-49A+/ 
Ly-49C-  cells  in DL6,  DL1,  and D8 mice  (Fig.  5).  They 
also  identified  this  subset  both  in  the  Da/La-positive  and 
the Dd/La-negative cell populations  of DL6 mice (Fig.  5). 
Although  we  cannot  exclude  minor  shifts,  we  conclude 
from this  that a  considerable  proportion of Ly-49A  +  cells 
in the DL6 mice do not express Ly-49C, making coexpres- 
sion of these two receptors a less likely explanation for tol- 
erance in DL6 mice. However, it is possible that Ly-49A+/ 
Ly-49C-  cells  express  other  not  yet identified  inhibitory 
receptors reactive with H-2  b molecules.  The SW5E6 anti- 
body used to stain for Ly-49C was recently shown to bind 
also  to the  product of another  member of the  same  gene 
family,  Ly-49I  (with  unknown  specificity  and  function; 
reference  43).  This  does not affect our conclusion, which 
rests  on  the  observation  of a  Ly-49A  ÷  population  that 
failed to stain with the SW5E6 antibody. 
Separation  of Da/La-positive  and  Da/La-negative  Cells In 
Vitro Abrogates NK  Cell  Tolerance to  Da/La-negative  Cells. 
To test whether tolerance against target cells lacking Da/L  d 
in the DL6 mice reflected an irreversible change in Da/L  a- 
positive  NK cells,  we separated  Da/La-positive  and  nega- 
tive DL6 cells.  After separation,  Da/La-positive and nega- 
tive spleen cells were cultured separately in the presence of 
rlL-2 for 4 d, and were then used as effector cells in vitro. 
In contrast with IL-2-activated effector cells from unsepa- 
rated DL6 splenocytes,  the  effector cells  from the  Da/L  a- 
positive  culture  killed  B6-derived  lymphoblasts  as  eft]- 
ciently as effector cells from DL1 mice (Fig. 6 A). The DO/ 
Ld-negative cells  were  still  unable  to lyse these  cells.  The 
ability  to lyse  [32m-deficient lymphoblasts  was retained  in 
both populations. The efficiency of the separation was high 
because  almost no negative  cells  could be detected in the 
NK Cell Tolerance in Mosaic MHC Class I Transgenic Mice 
;  .( 
Ly-49A 
Figure 5.  Three-color immunofluorescence  analysis of Ly-49 receptor 
expression on purified NK cells. NK cells were enriched from B6, D8, 
DL1, and DL6 splenocytes by passage over a nylon wool column fol- 
lowed by complement-depletion of cells expressing CD4, CD8, or MHC 
class II molecules. The remaining cells were triple-stained using mAbs 
specific for D  a od/a2, Ly-49A, and Ly-49C/I, and analyzed on a FACS- 
can  ®. Gates were set for D a cd/cx2-negative and D  a cd/oL2-positive  cells, 
and the plots show cells within either of  these gates as indicated. The cells 
consisted of 91% (B6), 86% (D8), 61% (DL1), 82% (DL6 Da/La-), and 
87% (DL6 Da/L  a+) NKI.1 + cells, respectively, and for all mice less than 
2% of  the cells expressing Ly-49A or Ly-49C/l were negative for NK1.1. 
One representative experiment of  three is shown. 
row cells by B6 mice is not reflected in vitro (17). The re- 
lationship  between  rejection  due  to  absence  of self and 
rejection due to presence of nonself is not known.  In any 
case, our data suggest that Da/La-negative and Da/La-posi- 
tive  NK cells in DL6 mice are mutually tolerized towards 
cells of the opposite phenotype. 
Tolerance in  DL6 Mice Does Not Extend  to  Cells with  a 
Generally  Reduced Expression  of MHC  Class  I  Molecules. 
To investigate whether the tolerance in DL6 mice was due 
to a  general  anergy in  the  NK cell population,  we  tested 
the ability of these mice to reject grafts deficient in expres- 
sion of the endogenous MHC  class I molecules K b and D b. 
Grafts  of the  tumor cell line  RMA-S,  a  TAP-2-deficient 
mutant of RMA, were rejected in DL6 mice as efficiently 
as in B6 mice (Table 2). Similarly, DL6 mice rejected ~2  m- 
deficient bone marrow equally well as B6 mice (see Fig. 3 
B).  In both  these  situations,  rejection was  abrogated  after 
treatment  of the recipient mice with anti-NKl.1  antibod- 
ies.  IL-2-activated  NK  cells  from  DL6  mice  also  killed 
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Figure 6.  In vitro cytotoxicity 
of Dd/La-positive and  Da/L a- 
negative  NK  cells from  DL6 
mice separated before IL-2 acti- 
vation. (A) Da/La-positive (trian- 
gles up) and Da/La-negative (tri- 
angles  down) spleen  cells from 
DL6  mice were  cultured sepa- 
rately in the presence oflL-2 and 
tested in a chromium release assay 
using  lymphoblasts from  B6, 
DL1, and B6 ~2m  -/- mice as tar- 
get cells. Effector cells from B6 
(circles), DL1 (diamonds), and un- 
separated  DL6  (squares) were 
tested in parallel. Target cells are 
indicated in the upper right cor- 
ner  of each graph. The  figure 
shows one representative experi- 
ment of three. (B) FACS  ®  analy- 
sis for Da/L a expression of the 
IL-2-activated NK cells used as 
effector cells in A. 
population of sorted Dd/La-positive DL6 effector cells (Fig. 
6  B).  This  result suggested that  the  tolerance  of the  DL6 
NK cells was dependent upon continuous presence of Da/ 
La-negative tolerizing cells, at least under the in vitro con- 
ditions used. 
To  exclude  that  development  of new  NK  cell  clones 
during the IL-2 culture was responsible for the abrogation 
of tolerance, we left the DL6 splenocytes unseparated until 
day 4  of the  IL-2 culture,  after which Dd/Ld-positive and 
negative cells were separated.  The cells were cultured sepa- 
rately for one additional day in the presence of IL-2 (to al- 
low for the beads to come of  0, and were then used as effec- 
tor cells in vitro. These recently separated Da/La-positive  cells 
killed B6-derived lymphoblasts as efficiently as the Dd/L  a- 
positive cells that were separated already before IL-2 activa- 
tion (Fig. 7). 
Discussion 
In this study, we have analyzed NK cell specificity in a 
transgenic mouse line with spontaneous mosaic expression 
of an  MHC  class  I  transgene.  In contrast  with  transgenic 
mice with expression  of the same transgene in all  cells,  no 
NK  cell-mediated  responses  could  be  observed  against 
transgene-negative  grafts  or  target  cells,  whereas  efficient 
elimination of cells with a general reduction of MHC  class 
I expression was seen. We propose that the mosaic pheno- 
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type  has  rendered  the  NK  system  specifically  tolerant  to 
one missing-self phenotype whereas  retaining reactivity to 
another. 
There  are  several  different  models  that  could  explain 
how host MHC  class I genes determine specificity and tol- 
erance  of the  NK cell  system.  These  models generally as- 
sume  that  NK  cells  that  can be  triggered by normal  cells 
must  express  at  least  one  type  of inhibitory  receptor  for 
host MHC  class  I molecules.  The most simple idea is that 
the MHC  class I molecules of the NK cell itself control the 
specificity;  for  example,  by facilitating  intracellular  trans- 
port  of certain  inhibitory  receptors  to  the  cell  surface. 
However, if this were the case, Da/La-expressing  NK  cells 
in DL6 mice should eliminate the transgene-negative cells. 
Therefore,  the  data argue against this model,  and in favor 
of models based on NK cell interactions with MHC  class I 
molecules  on  surrounding  cells  for  determination  of the 
repertoire. 
Such an NK cell education, dictated by other cells,  could 
occur in at least  two different ways: (a)  clonal selection of 
NK  cell  precursors  with  predetermined  receptor  expres- 
sion, and  (b)  cellular adaptation  during a phase in NK cell 
differentiation that allows for flexibility in terms of activa- 
tion  status  or  type(s)  and  levels  of receptors  expressed. 
Clonal  selection  could be  positive  or negative  (or both), 
would involve death of considerable numbers of unfit pre- 
cursors and would predict stable specificity patterns.  On the 50 
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Figure 7.  In vitro cytotoxicity 
of Da/La-positive  and  Da/L  d- 
negative  NK  cells from  DL6 
mice separated on day 4 of IL-2 
activation.  (A)  Da/La-positive 
(triangles up) and Da/La-negative 
(triangles down) spleen cells from 
DL6 mice were separated after 4 d 
of culture in the presence of IL-2, 
cultured separately for one addi- 
tional  day  and  subsequently 
tested in a chromium release assay 
using  lymphoblasts from  B6, 
DL1, and B6132m  -/- mice as tar- 
get cells. Effector cells from B6 
(circles), DL1 (diamonds), and un- 
separated  DL6  (squares) were 
tested in parallel. Target cells are 
indicated in the upper right cor- 
ner  of each graph. The  figure 
shows one representative experi- 
ment of two. (B) FACS  ®  analysis 
for Dd/L  a expression on the IL-2- 
activated NK cells used as effec- 
tor cells in A. 
other hand,  cellular adaptation,  might allow for survival of 
most  or  all  cells,  and  could  be  permanent  or  flexible 
throughout the lifespan of the NK cell.  Furthermore,  unfit 
cells could be adapted either by maintaining them as inac- 
tive,  i.e.,  anergic,  or as  active  NK  cells  but  with  altered 
specificity.  The latter  could occur through modulation  of 
the  levels  of the  expressed  inhibitory  receptor(s)  as  pro- 
posed in the receptor calibration model (29,  44),  or by de 
novo expression of other receptors  (30,  45).  In the  clonal 
selecfon  as  well  as  in  the  cellular  adaptation  model,  the 
outcome for the NK cell could be determined  in a  single 
interaction with the first cell encountered, or after scanning 
of several cells.  In case more than one cell is encountered, 
there  must be vales that decide  the  outcome if the MHC 
phenotype  of these  cells  vary  quantitatively,  as  they  are 
known to do between cell types and tissues. 
Our observations in the DL6 mice are relevant for sev- 
eral of the possibilities  above.  They argue against the idea 
of positive selection as the only mechanism involved in de- 
termining  NK  specificity.  Such  a  model  would postulate 
that NK cells carrying a certain inhibitory receptor are pos- 
itively selected on cells expressing the MHC  class  I hgand 
for this receptor,  and by this interaction survive and learn 
(irreversibly)  to  kill  cells  lacking  the  same  hgand.  If this 
were the case, a fair number,  if not all,  of the NK cells in 
DL6 mice would be educated to react against Dd/Ld-nega  - 
five cells, particularly in animals with a high percentage of 
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transgene-positive  cells.  This  was  not  observed,  arguing 
also against the possibility that NK cell specificity is deter- 
mined solely in the first encounter with a selecting or cali- 
brating cell. Our data thus suggest that (a) NK cells learn to 
tolerate self by interactions with multiple cells in their envi- 
ronment,  and  (b)  tolerance  against Dd/La-negative cells in 
the mosaic mice is dominantly determined by the presence 
of Da/Ld-negative  cells.  The second conclusion may at first 
sound  paradoxical,  but  it  should be  emphasized  that  NK 
cell  interaction  with  target  cells  expressing  a  missing-self 
phenotype occurs through a minimum of two recognition 
events (9).  First,  a triggering signal is induced during initial 
cell contact. Second, if the target cell expresses the correct 
MHC  class I molecules, an inhibitory signal is elicited that 
overrides  the  first  signal.  Absence  of the  second signal in 
presence of the first, during the effector phase, leads to kill- 
ing. However, in a selection process, this would instead re- 
sult in tolerance development through death of the precur- 
sor cell. In an adaptation process it would lead to expression of 
more or novel inhibitory receptors  (altered  specificity),  or 
downregulation of activating receptors or their signal trans- 
duction pathways (anergy). 
Finally, it should be stressed that even if our data argue 
that the presence of Dd/Ld-negative cells is responsible for 
tolerance,  we cannot exclude a role for positive  selection. 
In fact,  the possibility remains that positive recognition  of 
inhibitory ligands  operates  in  shaping the  NK  cell  reper- 
MHC Class I Transgenic Mice toire, although there is a superimposed process of dominant 
tolerance  development  dictated  by  cells  with  reduced 
ligand expression, as illustrated by the Dd/Ld-negative cells 
in  the  DL6  mice.  One  possibility is  that  Dd/Ld-negative 
cells by their mere presence interrupt repeated NK cell in- 
teractions  with Da/Ld-positive cells,  which  would  be re- 
quired to positively fix or maintain the capacity to kill Da/ 
La-negative cells.  However,  a  more  active  role  could  be 
postulated, in which these cells would (re)program the Da/ 
Ld-positive NK cells  for tolerance to cells  expressing only 
H-2  b molecules. 
Although  the  exact phenotype of NK cells  involved in 
rejection of Dd-negative transplants by Dd-positive hosts is 
unknown,  it  is  clear  that  the  NK  cells  of Dd-transgenic 
mice that kill Dd-negative cells in vitro belong to the subset 
expressing the D d receptor Ly-49A (29).  Therefore, it was 
puzzling that Ly-49A  ÷ NK cells are present in normal B6 
mice lacking D d (19).  If anything, the number of Ly-49A  + 
cells seems to be increased somewhat in Da-negative mice 
(30,  46).  However,  the  Ly-49A  +  subset  undergoes  two 
functional changes as a consequence  of introducing D a in 
the host. First,  the expression of Ly-49A is reduced by 40- 
70% compared with Ly-49A  ÷ cells in mice lacking D d (29, 
30).  This  may be  the  consequence  of calibrated  receptor 
levels,  where  the reduced  number of inhibitory receptors 
would  allow NK cells  to kill target cells  with moderately 
reduced  D a expression  (44).  Second,  Ly-49A  ÷  cells  from 
Da-transgenic mice kill Dd-negative cells whereas Ly-49A  + 
cells from DCnegative mice do not. High levels of the Ly- 
49A receptor are not responsible for self-tolerance in H-2  b 
mice, because tolerance to Dd-negative cells  could not be 
reversed by antibodies  against Ly-49A receptors  (47).  To 
account  for self-tolerance,  coexpression  of additional  re- 
ceptors  (in  this  case for H-2  u molecules)  has instead been 
suggested (29,  47).  Furthermore,  a recent report, showing 
that forced expression of a transgenic Ly-49A receptor on 
all NK cells  in H-2  b mice induced tolerance to allogeneic 
H-2  d grafts (48),  also implies that such a mechanism could 
be eflScient  in contracting the NK cell repertoire, and pos- 
sibly also to secure self-tolerance. 
DL6 mice were tolerant to Dd-negative cells  in spite of 
downregulated Ly-49A expression (Fig.  5), again implying 
that  Ly-49A levels  are  unrelated  to  tolerance  against D a- 
negative grafts.  Furthermore, when Ly-49A  + cells  in mo- 
saic mice were analyzed for coexpression of receptors bind- 
ing to the antibody SW5E6,  one of which is Ly-49C with 
specificity for H-2K  b (Fig.  5),  no  major differences were 
observed compared with nontolerant DL1 or D8 mice. Al- 
though we can not exclude minor shifts between the popu- 
lations,  it  appears  as  if tolerance  to  Dd-negative  cells  by 
Da-positive/Ly-49A  +  NK  cells  in  DL6  mice  can  not  be 
explained by coexpression of Ly-49C receptors. However, 
other still unidentified receptors for H-2  u may be involved, 
as suggested in previous studies  (29,  47).  It is noteworthy 
that the  expression levels of Ly-49A were downregnlated 
to  a  similar  extent,  if not  more,  in  the  Da/Ld-negative 
compared with the  Dd/Ld-positive NK cell population in 
DL6 mice  (Fig.  5).  This observation emphasizes that cali- 
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bration of Ly-49 receptors by host MHC  molecules does 
not require expression of the relevant class I hgands by the 
NK cell itself.  The pattern ofdownregulation of Ly-49A in 
the mosaic mice also shows that Dd/Ld-positive cells exert a 
dominant influence on this calibration process. 
Our  data  further  raise  the  possibility that  the  NK cell 
repertoire may not be permanently fixed. Tolerance of NK 
cells  tested  after culture  in  IL-2 was  abrogated if Dd/L  d- 
positive cells were separated from negative cells before the 
test,  and  the  ability to kill Dd/Ld-negative cells  was  con- 
fined to the Da/Ld-positive population.  Thus, the data are 
consistent  with  an  adaptation  process  where  the  relevant 
NK cells within the Dd/Ld-positive population survive, but 
are maintained anergic or specifically unable to kill H-2  b- 
positive, Dd/La-negative cells.  It may be argued that IL-2 
could induce de novo expansion and selection of immature 
NK  cell  clones  in  the  absence  of Dd/Ld-expressing  cells 
during the  culture  period of 4  d.  However, we  observed 
the same abrogation of tolerance when Dd/Ld-positive and 
negative cells were maintained together during most of the 
culture period, and separated only for the last 24 h. Clonal 
selection and expansion during such a limited time period 
is  unlikely,  and  the  data  therefore  argue  for a  switch  of 
specificity, or reversal of anergy state, at the level of the in- 
dividual NK cell, i.e., a cellular adaptation process. One in- 
teresting possibility is that such changes reflect a flexibility 
in the  calibration of the mature NK cell,  such that it can 
adapt to differences in MHC expression related to cell type, 
inflammatory cytokines.  However,  the  question  whether 
the repertoire of mature NK cells is subject to such changes 
in  vivo  remains  to  be  investigated,  because  the  in  vitro 
conditions with high levels of IL-2 used here may induce 
or accelerate unphysiological cellular changes involved in 
the process.  However, it is difficult to exclude  IL-2 from 
the experimental system because this cytokine is necessary 
for  the  generation  of NK  cells  that  display  allelic  MHC 
class  I specificities in vitro  (17,  41).  At this stage, we  can 
conclude that tolerance of NK cells in DL6 mice is not due 
to complete deletion of cells that can recognize Dd/Ld-neg  - 
ative cells. 
An interesting  observation was that DL6 mice also  lost 
the ability to reject D8 bone marrow grafts,  a rejection that 
is seen in normal B6 mice (15,  42).  It has been suggested 
that this rejection would reflect positive recognition of for- 
eign MHC class I antigens by NK cells, a pathway that may 
be specially important for the function of rat NK cells (49). 
The  mechanistical  relationship  between  these  two  path- 
ways of NK cell killing has not been established, but these 
two apparently contradictory roles of MHC  class I  mole- 
cules in NK cell function need not be mutually exclusive. 
In fact, recent data in humans suggest that certain receptors 
for MHC class I molecules can mediate either triggering or 
inhibition of NK cells depending upon the structure of the 
intracellular  domains  (22,  50).  The finding  that  the  DL6 
mice were tolerant against both Dd-negative and Dd-posi  - 
tive grafts suggests that recognition in these two situations, 
at least when it comes to tolerance  development, may be 
more  similar  than  appreciated.  However,  it  should  be noted that formal evidence that B6 NK cells positively rec- 
ognize D a as a triggering stimulus is lacking, and other expla- 
nations for this allorecognition have been suggested (15, 42). 
Several previous studies have aimed at establishing short 
or long-term NK cell tolerance to grafts of different MHC 
phenotype,  ususally based on inoculation of large number 
of parental  bone marrow or tumor cells  at  different time- 
points before bone marrow grafting.  (5,  31-36).  However, 
it is difficult, in these studies,  to differentiate between spe- 
cific tolerizing effects  on NK cells and nonspecific immuno- 
suppressive  effects  caused by graft versus  host  disease,  re- 
sulting  from  recognition  of  hybrid  MHC  antigens  by 
parental  T  cells.  (51-53).  In  the  case  of DL6  mice,  the 
problems with graft versus host disease  were avoided. We 
could not detect any Da/La-specific responses using mixed 
lymphocyte culture with DL6 responder spleen cells, whereas 
they  responded  well  to  third-party  stimulators  (data  not 
shown).  Our  results  also  suggest  that  long-standing  bone 
marrow  chimerism  may  explain  the  results  obtained  by 
Waterfall et al.  (33), where newborn mice, pretreated with 
parental bone marrow cells within the first 24 h  after birth, 
were tolerant to parental grafts 3 mo later. 
Abnormal  expression  patterns  are  known  to  occur  in 
transgenic  lines.  However,  they  are  seldom  followed  up 
systematically and reported,  presumably because  transgene 
expression  is usually not assessed on single cells but rather 
using  tkNA  analysis  on  extracts  from whole  organs.  We 
have identified two additional MHC  class I transgenic lines 
with  an expression pattern  similar  to  the  DL6 line,  and  a 
similar phenotype has also been recently reported for mice 
carrying a  human  CD2 transgene  (54-55).  A  possible  ex- 
planation is that the integration site of the transgene puts it 
at  risk  for  inactivation  (or  activation)  on  both  chromo- 
somes  early  during  embryonic  development.  Stochastic 
variations injunctions between active and inactive chroma- 
tin associated with this integration site may form the basis 
for  an  individual  pattern  of transgene  expression  in  each 
mouse.  This would be reminiscent  of the  spreading effect 
in  position  effect variegation  described  in  Drosophila (re- 
viewed  in  reference  56).  DL6  mice  homozygous for the 
transgene  also  had  a  mosaic phenotype  (data  not shown), 
consistent with variegation but arguing against allelic inac- 
tivation as the mechanism behind mosaicism. 
Host MHC control of NK cell specificity may ultimately 
depend on several mechanisms, such as clonal selection/de- 
letion  and  cellular adaptation,  the  latter  including  anergy, 
receptor  calibration,  and de novo expression  of receptors. 
So far, the MHC class I mosaic mice have provided support 
for the existence of cellular adaptation mechanisms leading 
to selective tolerance to one particular missing-self pheno- 
type but not to another.  Furthermore,  tolerance appears to 
be determined by interaction with multiple  cells  in a pro- 
cess where MHC  class  I ligand defective  cells  dominantly 
control tolerance to this phenotype without complete dele- 
tion of the potentially autoreactive NK cell subset(s).  Such 
persisting,  potentially  autoreactive  NK cells  can be reacti- 
vated in vitro in an environment dominated by cells  with 
complete ligand expression.  Further studies are required to 
understand  whether  this  reflects  an  important  adaptive 
component in mature  NK cell function in vivo, how the 
presence  of  ligand  defective  cells  induces  and  perhaps 
maintains tolerance,  and whether selection/deletion  is also 
operating to ensure tolerance to self. 
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